S&P 500   3,881.08 (-2.33%)
DOW   31,420.47 (-1.44%)
QQQ   284.24 (-3.15%)
AAPL   138.54 (-3.19%)
MSFT   255.97 (-1.80%)
FB   177.71 (-9.44%)
GOOGL   2,064.00 (-7.43%)
AMZN   2,062.60 (-4.12%)
TSLA   638.77 (-5.35%)
NVDA   160.95 (-4.75%)
BABA   82.93 (-4.93%)
NIO   14.74 (-7.88%)
AMD   91.49 (-3.77%)
CGC   4.93 (-5.01%)
MU   66.94 (-3.81%)
T   20.64 (-0.48%)
GE   72.54 (-3.87%)
F   12.34 (-3.82%)
DIS   100.47 (-5.06%)
AMC   10.56 (-8.81%)
PFE   52.82 (-0.11%)
PYPL   77.73 (-4.25%)
NFLX   178.49 (-4.77%)
S&P 500   3,881.08 (-2.33%)
DOW   31,420.47 (-1.44%)
QQQ   284.24 (-3.15%)
AAPL   138.54 (-3.19%)
MSFT   255.97 (-1.80%)
FB   177.71 (-9.44%)
GOOGL   2,064.00 (-7.43%)
AMZN   2,062.60 (-4.12%)
TSLA   638.77 (-5.35%)
NVDA   160.95 (-4.75%)
BABA   82.93 (-4.93%)
NIO   14.74 (-7.88%)
AMD   91.49 (-3.77%)
CGC   4.93 (-5.01%)
MU   66.94 (-3.81%)
T   20.64 (-0.48%)
GE   72.54 (-3.87%)
F   12.34 (-3.82%)
DIS   100.47 (-5.06%)
AMC   10.56 (-8.81%)
PFE   52.82 (-0.11%)
PYPL   77.73 (-4.25%)
NFLX   178.49 (-4.77%)
S&P 500   3,881.08 (-2.33%)
DOW   31,420.47 (-1.44%)
QQQ   284.24 (-3.15%)
AAPL   138.54 (-3.19%)
MSFT   255.97 (-1.80%)
FB   177.71 (-9.44%)
GOOGL   2,064.00 (-7.43%)
AMZN   2,062.60 (-4.12%)
TSLA   638.77 (-5.35%)
NVDA   160.95 (-4.75%)
BABA   82.93 (-4.93%)
NIO   14.74 (-7.88%)
AMD   91.49 (-3.77%)
CGC   4.93 (-5.01%)
MU   66.94 (-3.81%)
T   20.64 (-0.48%)
GE   72.54 (-3.87%)
F   12.34 (-3.82%)
DIS   100.47 (-5.06%)
AMC   10.56 (-8.81%)
PFE   52.82 (-0.11%)
PYPL   77.73 (-4.25%)
NFLX   178.49 (-4.77%)
S&P 500   3,881.08 (-2.33%)
DOW   31,420.47 (-1.44%)
QQQ   284.24 (-3.15%)
AAPL   138.54 (-3.19%)
MSFT   255.97 (-1.80%)
FB   177.71 (-9.44%)
GOOGL   2,064.00 (-7.43%)
AMZN   2,062.60 (-4.12%)
TSLA   638.77 (-5.35%)
NVDA   160.95 (-4.75%)
BABA   82.93 (-4.93%)
NIO   14.74 (-7.88%)
AMD   91.49 (-3.77%)
CGC   4.93 (-5.01%)
MU   66.94 (-3.81%)
T   20.64 (-0.48%)
GE   72.54 (-3.87%)
F   12.34 (-3.82%)
DIS   100.47 (-5.06%)
AMC   10.56 (-8.81%)
PFE   52.82 (-0.11%)
PYPL   77.73 (-4.25%)
NFLX   178.49 (-4.77%)
NASDAQ:XSPA

XpresSpa Group (XSPA) Stock Forecast, Price & News

$0.72
-0.01 (-1.38%)
(As of 05/24/2022 10:11 AM ET)
Add
Compare
Today's Range
$0.72
$0.72
50-Day Range
$0.73
$1.49
52-Week Range
$0.72
$2.19
Volume
1,135 shs
Average Volume
1.46 million shs
Market Capitalization
$68.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.33
30 days | 90 days | 365 days | Advanced Chart
Receive XSPA News and Ratings via Email

Sign-up to receive the latest news and ratings for XpresSpa Group and its competitors with MarketBeat's FREE daily newsletter.

XpresSpa Group logo

About XpresSpa Group

XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Personal services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:XSPA
Employees
363
Year Founded
N/A

Sales & Book Value

Annual Sales
$73.73 million
Cash Flow
$0.07 per share
Book Value
$0.92 per share

Profitability

Net Income
$3.35 million
Pretax Margin
1.11%

Debt

Price-To-Earnings

Miscellaneous

Free Float
94,416,000
Market Cap
$68.65 million
Optionable
Optionable

Company Calendar

Last Earnings
3/15/2022
Today
5/24/2022
Next Earnings (Estimated)
8/15/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.39 out of 5 stars

Medical Sector

206th out of 1,423 stocks

Personal Services Industry

5th out of 20 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -













XpresSpa Group (NASDAQ:XSPA) Frequently Asked Questions

Is XpresSpa Group a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for XpresSpa Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" XpresSpa Group stock.
View analyst ratings for XpresSpa Group
or view top-rated stocks.

When is XpresSpa Group's next earnings date?

XpresSpa Group is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for XpresSpa Group
.

How were XpresSpa Group's earnings last quarter?

XpresSpa Group, Inc. (NASDAQ:XSPA) issued its quarterly earnings data on Tuesday, March, 15th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0.03. The business earned $29.36 million during the quarter, compared to the consensus estimate of $27.14 million. XpresSpa Group had a trailing twelve-month return on equity of 0.13% and a net margin of 0.14%.
View XpresSpa Group's earnings history
.

When did XpresSpa Group's stock split? How did XpresSpa Group's stock split work?

Shares of XpresSpa Group reverse split before market open on Thursday, June 11th 2020. The 1-3 reverse split was announced on Wednesday, June 10th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 10th 2020. An investor that had 100 shares of XpresSpa Group stock prior to the reverse split would have 33 shares after the split.

What price target have analysts set for XSPA?

1 analysts have issued 1 year target prices for XpresSpa Group's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate XpresSpa Group's stock price to reach $2.00 in the next year. This suggests a possible upside of 177.8% from the stock's current price.
View analysts' price targets for XpresSpa Group
or view top-rated stocks among Wall Street analysts.

Who are XpresSpa Group's key executives?
XpresSpa Group's management team includes the following people:
  • Mr. Scott R. Milford, Pres, CEO & Director (Age 58, Pay $369.58k)
  • Mr. James A. Berry, CFO and Principal Financial & Accounting Officer (Age 65, Pay $216.34k) (LinkedIn Profile)
  • Mr. David Kohel, Chief Technology Officer
  • Ms. Cara Soffer, Sr. VP & Gen. Counsel
  • Mr. Omar Haynes, VP of Treasury & Fin.
  • Mr. Ezra Ernst, Chief Exec. Officer of XpresCheck
What other stocks do shareholders of XpresSpa Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other XpresSpa Group investors own include Genius Brands International (GNUS), Boeing (BA), NVIDIA (NVDA), Carnival Co. & (CCL), Heat Biologics (HTBX), Inovio Pharmaceuticals (INO), NIO (NIO), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO) and Vislink Technologies (VISL).

What is XpresSpa Group's stock symbol?

XpresSpa Group trades on the NASDAQ under the ticker symbol "XSPA."

Who are XpresSpa Group's major shareholders?

XpresSpa Group's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.44%), State Street Corp (0.34%), Group One Trading L.P. (0.00%), Goldman Sachs Group Inc. (0.24%), Virtu Financial LLC (0.16%) and Simplex Trading LLC (0.00%). Company insiders that own XpresSpa Group stock include Bruce Bernstein, Doug Satzman, James A Berry, Robert Weinstein and Scott R Milford.
View institutional ownership trends for XpresSpa Group
.

Which institutional investors are selling XpresSpa Group stock?

XSPA stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Goldman Sachs Group Inc., Simplex Trading LLC, Jane Street Group LLC, and Cutler Group LP. Company insiders that have sold XpresSpa Group company stock in the last year include Bruce Bernstein, Doug Satzman, Robert Weinstein, and Scott R Milford.
View insider buying and selling activity for XpresSpa Group
or view top insider-selling stocks.

Which institutional investors are buying XpresSpa Group stock?

XSPA stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Group One Trading L.P., Virtu Financial LLC, Renaissance Technologies LLC, State Street Corp, and Commonwealth Equity Services LLC. Company insiders that have bought XpresSpa Group stock in the last two years include Bruce Bernstein, and James A Berry.
View insider buying and selling activity for XpresSpa Group
or or view top insider-buying stocks.

How do I buy shares of XpresSpa Group?

Shares of XSPA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is XpresSpa Group's stock price today?

One share of XSPA stock can currently be purchased for approximately $0.72.

How much money does XpresSpa Group make?

XpresSpa Group has a market capitalization of $68.65 million and generates $73.73 million in revenue each year.

How many employees does XpresSpa Group have?

XpresSpa Group employs 363 workers across the globe.

What is XpresSpa Group's official website?

The official website for XpresSpa Group is www.xpresspagroup.com.

How can I contact XpresSpa Group?

XpresSpa Group's mailing address is 254 WEST 31ST STREET 11TH FLOOR, NEW YORK NY, 10001. The company can be reached via phone at (212) 309-7549, via email at [email protected], or via fax at 309-410-3967.

This page was last updated on 5/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.